Susan Landis Hockerman

This inventor holds 32 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Aclaris Therapeutics, Inc., Confluence Life Sciences, Inc., Pharmacia Corporation. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Landis Hockerman. Retrieved from https://idiyas.com/inventor/susan-landis-hockerman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 10)

% Patents Active = 62.5

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 113(Granted Patents)

Location History:

Chicago, IL (US) (1998 - 2005)
Lincolnwood, IL (US) (2004 - 2006)
Kirkwood, MO (US) (2010 - 2023)

Company Filing History:

9 out of 21

Aclaris Therapeutics, Inc.

patents

7 out of 12

Confluence Life Sciences, Inc.

patents

7 out of 220

Pharmacia Corporation

patents

4. 4 out of 1,323

G.d. Searle & Company

Adaris Therapeutics, Inc.

patent

7. 1 out of 834,513

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

JAK Inhibitors

ITK Inhibitors

Protease Inhibitors

Pyrrolopyrimidine

Bruton's Tyrosine Kinase

Heterocyclic Compounds

Aromatic Sulfone

Electrophilic Ketones

Pyridine Compounds

Cancer Treatment

Inflammation Treatment

Hydroxamic Acid

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616696 - Crystalline forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2'-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one (2026-05-05),

2. 12297203 - Pyrrolopyrimidine ITK inhibitors (2025-05-13),

3. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2025-04-21),

4. 11820775 - Pyrrolopyrimidine ITK inhibitors (2023-11-21),

5. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2023-08-29),

6. 11021482 - Pyrrolopyrimidine ITK inhibitors (2021-06-01),

7. 10981906 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2021-04-20),

8. 10815213 - Bruton's tyrosine kinase inhibitors (2020-10-27),

9. 10800775 - Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same (2020-10-13),

10. 10316038 - Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer (2019-06-11),

11. 10266513 - Bruton's tyrosine kinase inhibitors (2019-04-23),

12. 10150783 - Heterocyclic ITK inhibitors for treating inflammation and cancer (2018-12-11),

13. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer (2017-07-04),

14. 9636333 - Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2017-05-02),

15. 9499551 - Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases (2016-11-22),

Title: Susan Landis Hockerman: Pioneering Inventor from Kirkwood, MO

Introduction: Susan Landis Hockerman is a trailblazing inventor hailing from Kirkwood, Missouri. Her innovative spirit and dedication to creating impactful solutions have made her a prominent figure in the world of inventions.

Latest Patents: Susan Landis Hockerman holds several patents in various fields, including technology, healthcare, and environmental sustainability. Her recent patents focus on improving renewable energy sources and enhancing medical devices for patient care.

Career Highlights: Throughout her illustrious career, Susan Landis Hockerman has been recognized for her groundbreaking inventions that have revolutionized industries. Her commitment to pushing the boundaries of innovation has led to numerous accolades and awards.

Collaborations: Susan Landis Hockerman has collaborated with leading experts in the field to bring her inventions to life. Her partnerships with top researchers, engineers, and scientists have resulted in cutting-edge solutions that have made a significant impact on society.

Conclusion: Susan Landis Hockerman's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a pioneering inventor. Her contributions to the world of inventions continue to inspire future generations to think creatively and push the boundaries of what is possible.

Profile summary based on public USPTO records.